查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1914677

皮膚填充劑市場－全球產業規模、佔有率、趨勢、機會和預測：按類型、材料類型、應用、性別、最終用戶、地區和競爭格局分類，2021-2031年

Dermal Fillers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Material Type, By Application, By Gender, By End User, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 181 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球皮膚填充劑市場預計將從 2025 年的 78.1 億美元成長到 2031 年的 123.8 億美元，複合年成長率為 7.98%。

這些可注射的凝膠狀物質用於美容嫩膚，以減少皺紋、改善臉部輪廓並恢復流失的容量。市場成長的主要驅動力是全球人口老化以及消費者對非侵入性、恢復期短、效果立竿見影的美容方案的強烈偏好。然而，由於不良副作用和併發症的風險，該行業面臨著巨大的挑戰，這需要嚴格的監管，並且可能會讓謹慎的患者望而卻步。

市場概覽
預測期 2027-2031
市場規模：2025年 78.1億美元
市場規模：2031年 123.8億美元
複合年成長率：2026-2031年 7.98%
成長最快的細分市場 玻尿酸
最大的市場 北美洲

根據國際美容整形外科學會的數據，預計到2024年，全球整體使用玻尿酸的整形手術數量將增加5.2%，達到630萬例。這項數據凸顯了整個美容醫學領域對軟組織填充的持續需求。

市場促進因素

推動全球皮膚填充劑市場成長的關鍵因素是人們對微創、非手術美容療程的需求日益成長。由於恢復時間更快、併發症風險更低以及效果更立竿見影，患者越來越傾向於選擇注射療法而非手術。美國整形外科醫師協會於2024年6月發布的《2023年整形外科統計報告》印證了這一趨勢，該報告記錄了超過530萬例透明質酸填充劑注射。此外，區域成長也十分強勁。英國美容整形外科醫師協會於2024年4月發布的《2023年年度審核報告》顯示，其會員所進行的非手術皮膚填充劑注射數量較去年同期增加了27%。

此外，填充配方方面的技術創新，例如先進的交聯技術和能夠刺激膠原蛋白生成並改善皮膚品質的生物刺激產品，正在推動市場擴張。這些進步使得針對更廣泛患者群體的個人化治療成為可能，從豐唇到深度塑形，不一而足。這些創新帶來的財務影響顯而易見：高德美公司於2024年10月發布的「2024年第三季」業績報告顯示，其注射美容部門的淨銷售額按外匯計算同比成長10.6%，這主要得益於全球市場對公司產品系列的需求。

市場挑戰

全球皮膚填充劑市場面臨的主要障礙之一是持續存在的併發症和不良副作用風險，這不僅需要嚴格的監管，也導致消費者猶豫不決。隨著市場成長，無證件從業人員和不受監管的產品也隨之增多，同時，與手術相關的損傷，例如嚴重感染疾病和血管阻塞，也日益增多。這些安全問題削弱了消費者的信心，並迫使各國政府實施嚴格的核准通訊協定和執業限制，從而提高了市場准入門檻，延緩了產品商業化進程。

這些安全問題的嚴重性在修訂資料中顯而易見。英國美容醫學學院報告稱，其成員在2024年處理了3547例由其他從業人員造成的併發症，這表明存在大量不合格的治療結果。這些問題的曝光加劇了潛在患者的風險規避心理，限制了潛在市場，並持續限制產業發展。

市場趨勢

重塑市場格局的關鍵趨勢之一是男性美容療程的激增。越來越多的男性尋求透過注射填充劑來增強臉部男性特徵並塑造輪廓。女性患者往往更注重中部容量的提升，而男性則越來越追求更清晰、更有型的下顎線和下巴，打破了傳統的性別刻板印象。美國面部整形與重組外科協會於2025年2月發布的《2024年度調查統計數據》凸顯了這一轉變，數據顯示，92%的外科醫生表示曾治療過男性患者，表明該手術已被廣泛接受。

同時，消費者越來越傾向於低調自然的美容效果，這推動了對能夠提升而非改變個人面部特徵的微調的需求。患者逐漸摒棄了過度填充帶來的不自然效果，轉而選擇微劑量注射技術，這種技術能夠在保持臉部彈性的同時，帶來不易察覺的改善。 Merz Aesthetics 於 2025 年 1 月進行的「自信基石」調查也印證了這種對自然美的追求，其中 69% 的受訪者表示他們希望接受的治療能夠「反映他們的內心感受」。這表明，人們越來越傾向於將內在自我與外在形象相協調。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球皮膚填充劑市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依類型（可生物分解、不可生物分解）
    • 依材料種類（透明質酸、烴基磷灰石鈣、聚左旋乳酸、聚甲基丙烯酸甲酯微粒[PMMA]、其他）
    • 依應用領域（除皺治療、臉部細紋矯正、拉皮、豐唇、疤痕治療）
    • 性別（女性與男性）
    • 按最終使用者（皮膚科診所、醫院、美容診所等）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美皮膚填充劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲皮膚填充劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區皮膚填充劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲皮膚填充劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲皮膚填充劑市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球皮膚填充劑市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • AbbVie Inc.
  • Galderma SA
  • Merz Pharmaceuticals GmbH
  • Revance Therapeutics, Inc.
  • Huadong Medicine Co., Ltd.
  • Teoxane SA
  • Anika Therapeutics, Inc.
  • Suneva Medical, Inc.
  • BioPlus Co., Ltd.
  • Prollenium Medical Technologies

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 5109

The Global Dermal Fillers Market is projected to expand from USD 7.81 Billion in 2025 to USD 12.38 Billion by 2031, reflecting a compound annual growth rate of 7.98%. These injectable gel-like substances are utilized for aesthetic rejuvenation, aiming to smooth lines, enhance facial contours, and restore lost volume. Market growth is largely fueled by a global aging population and a notable consumer preference for non-invasive cosmetic options that provide immediate results with little downtime. However, the industry encounters significant challenges due to the risk of adverse side effects and complications, which require rigorous regulatory monitoring and may discourage cautious patients.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 7.81 Billion
Market Size 2031USD 12.38 Billion
CAGR 2026-20317.98%
Fastest Growing SegmentHyaluronic Acid
Largest MarketNorth America

According to the International Society of Aesthetic Plastic Surgery, hyaluronic acid procedures increased by 5.2 percent in 2024, reaching a total of 6.3 million procedures globally. This data highlights the enduring demand for soft tissue augmentation within the broader field of aesthetic medicine.

Market Driver

The primary force driving the Global Dermal Fillers Market is the escalating demand for minimally invasive and non-surgical aesthetic treatments. Patients increasingly favor injectables over surgical alternatives due to shorter recovery periods, lower complication risks, and more immediate visual results. This preference is evidenced by the American Society of Plastic Surgeons' '2023 Plastic Surgery Statistics Report' released in June 2024, which recorded over 5.3 million hyaluronic acid filler procedures. Additionally, regional growth is robust; the British Association of Aesthetic Plastic Surgeons noted in their April 2024 'Annual Audit 2023' that non-surgical dermal filler treatments among members rose by 27 percent from the previous year.

Market expansion is further catalyzed by technological innovations in filler formulations, including advanced cross-linking techniques and biostimulatory products that enhance skin quality by stimulating collagen production. These developments allow for tailored treatments ranging from lip augmentation to deep structural contouring, broadening the patient base. The financial impact of these innovations is clear, as Galderma reported in its 'Third Quarter 2024 Financial Results' in October 2024 that net sales for its Injectable Aesthetics unit increased by 10.6 percent year-on-year on a constant currency basis, fueled by global demand for its portfolio.

Market Challenge

The main obstacle facing the Global Dermal Fillers Market is the ongoing risk of complications and adverse side effects, which necessitates strict regulatory control and causes consumer hesitation. As the market grows, an increase in unqualified practitioners and unregulated products has led to procedure-related injuries such as severe infections and vascular occlusions. These safety issues undermine consumer trust and force governments to enforce rigorous approval protocols and practice restrictions, creating barriers to entry and slowing product commercialization.

The magnitude of these safety challenges is underscored by data on corrective treatments. The British College of Aesthetic Medicine reported in 2024 that its members treated 3,547 complications caused by other practitioners, indicating a significant volume of substandard outcomes. The visibility of such issues reinforces risk aversion among potential patients, limiting the addressable market and acting as a continuous restraint on industry growth.

Market Trends

A significant trend reshaping the market is the surge in male aesthetic treatments, with men increasingly seeking dermal fillers for facial masculinization and structural contouring. Unlike female patients who may focus on mid-face volume, male demographics often seek to project a stronger jawline and chin for a more defined look, breaking down historical stigmas. This shift is highlighted by the American Academy of Facial Plastic and Reconstructive Surgery's '2024 Annual Survey Statistics' from February 2025, in which 92 percent of surgeons reported treating male patients, signaling widespread normalization.

Concurrently, there is a growing consumer preference for subtle, natural-looking outcomes, driving demand for 'tweakments' that enhance rather than alter individual anatomy. Patients are moving away from overfilled appearances in favor of micro-dosing techniques that maintain facial mobility and provide undetectable improvements. This desire for authenticity is supported by Merz Aesthetics' 'Pillars of Confidence' study from January 2025, where 69 percent of respondents expressed a desire for treatments that reflect their inner feelings, emphasizing a shift toward personal congruency.

Key Market Players

  • AbbVie Inc.
  • Galderma S.A.
  • Merz Pharmaceuticals GmbH
  • Revance Therapeutics, Inc.
  • Huadong Medicine Co., Ltd.
  • Teoxane S.A.
  • Anika Therapeutics, Inc.
  • Suneva Medical, Inc.
  • BioPlus Co., Ltd.
  • Prollenium Medical Technologies

Report Scope

In this report, the Global Dermal Fillers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Dermal Fillers Market, By Type

  • Biodegradable
  • Non-Biodegradable

Dermal Fillers Market, By Material Type

  • Hyaluronic Acid
  • Calcium Hydroxylapatite
  • Poly-L-lactic Acid
  • Polymethyl-methacrylate Microspheres [PMMA]
  • Others

Dermal Fillers Market, By Application

  • Wrinkle Correction Treatment
  • Facial Line Correction
  • Face Lift
  • Lip Enhancement
  • Scar Treatment

Dermal Fillers Market, By Gender

  • Female
  • Male

Dermal Fillers Market, By End User

  • Dermatology Clinics
  • Hospitals
  • Beauty Clinics
  • Others

Dermal Fillers Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Dermal Fillers Market.

Available Customizations:

Global Dermal Fillers Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Dermal Fillers Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Biodegradable, Non-Biodegradable)
    • 5.2.2. By Material Type (Hyaluronic Acid, Calcium Hydroxylapatite, Poly-L-lactic Acid, Polymethyl-methacrylate Microspheres [PMMA], Others)
    • 5.2.3. By Application (Wrinkle Correction Treatment, Facial Line Correction, Face Lift, Lip Enhancement, Scar Treatment)
    • 5.2.4. By Gender (Female v/s Male)
    • 5.2.5. By End User (Dermatology Clinics, Hospitals, Beauty Clinics, Others)
    • 5.2.6. By Region
    • 5.2.7. By Company (2025)
  • 5.3. Market Map

6. North America Dermal Fillers Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Material Type
    • 6.2.3. By Application
    • 6.2.4. By Gender
    • 6.2.5. By End User
    • 6.2.6. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Dermal Fillers Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Material Type
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By Gender
        • 6.3.1.2.5. By End User
    • 6.3.2. Canada Dermal Fillers Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Material Type
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By Gender
        • 6.3.2.2.5. By End User
    • 6.3.3. Mexico Dermal Fillers Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Material Type
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By Gender
        • 6.3.3.2.5. By End User

7. Europe Dermal Fillers Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Material Type
    • 7.2.3. By Application
    • 7.2.4. By Gender
    • 7.2.5. By End User
    • 7.2.6. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Dermal Fillers Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Material Type
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By Gender
        • 7.3.1.2.5. By End User
    • 7.3.2. France Dermal Fillers Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Material Type
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By Gender
        • 7.3.2.2.5. By End User
    • 7.3.3. United Kingdom Dermal Fillers Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Material Type
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By Gender
        • 7.3.3.2.5. By End User
    • 7.3.4. Italy Dermal Fillers Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Material Type
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By Gender
        • 7.3.4.2.5. By End User
    • 7.3.5. Spain Dermal Fillers Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Material Type
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By Gender
        • 7.3.5.2.5. By End User

8. Asia Pacific Dermal Fillers Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Material Type
    • 8.2.3. By Application
    • 8.2.4. By Gender
    • 8.2.5. By End User
    • 8.2.6. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Dermal Fillers Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Material Type
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By Gender
        • 8.3.1.2.5. By End User
    • 8.3.2. India Dermal Fillers Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Material Type
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By Gender
        • 8.3.2.2.5. By End User
    • 8.3.3. Japan Dermal Fillers Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Material Type
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By Gender
        • 8.3.3.2.5. By End User
    • 8.3.4. South Korea Dermal Fillers Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Material Type
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By Gender
        • 8.3.4.2.5. By End User
    • 8.3.5. Australia Dermal Fillers Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Material Type
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By Gender
        • 8.3.5.2.5. By End User

9. Middle East & Africa Dermal Fillers Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Material Type
    • 9.2.3. By Application
    • 9.2.4. By Gender
    • 9.2.5. By End User
    • 9.2.6. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Dermal Fillers Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Material Type
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By Gender
        • 9.3.1.2.5. By End User
    • 9.3.2. UAE Dermal Fillers Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Material Type
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By Gender
        • 9.3.2.2.5. By End User
    • 9.3.3. South Africa Dermal Fillers Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Material Type
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By Gender
        • 9.3.3.2.5. By End User

10. South America Dermal Fillers Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Material Type
    • 10.2.3. By Application
    • 10.2.4. By Gender
    • 10.2.5. By End User
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Dermal Fillers Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Material Type
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By Gender
        • 10.3.1.2.5. By End User
    • 10.3.2. Colombia Dermal Fillers Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Material Type
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By Gender
        • 10.3.2.2.5. By End User
    • 10.3.3. Argentina Dermal Fillers Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Material Type
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By Gender
        • 10.3.3.2.5. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Dermal Fillers Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. AbbVie Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Galderma S.A.
  • 15.3. Merz Pharmaceuticals GmbH
  • 15.4. Revance Therapeutics, Inc.
  • 15.5. Huadong Medicine Co., Ltd.
  • 15.6. Teoxane S.A.
  • 15.7. Anika Therapeutics, Inc.
  • 15.8. Suneva Medical, Inc.
  • 15.9. BioPlus Co., Ltd.
  • 15.10. Prollenium Medical Technologies

16. Strategic Recommendations

17. About Us & Disclaimer